Sung JJ et al. |
One-week use of ranitidine bismuth citrate, amoxycillin and clarithromycin for the treatment of Helicobacter pylori-related duodenal ulcer. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9726384
|
Pazzi P et al. |
Short-term low-dose pantoprazole-based triple therapy for cure of Helicobacter pylori infection in duodenal ulcer patients. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9726385
|
Harris AW et al. |
Incidence of duodenal ulcer healing after 1 week of proton pump inhibitor triple therapy for eradication of Helicobacter pylori. The Lansoprazole Helicobacter Study Group. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9726387
|
Bayoumi AM and Redelmeier DA |
Preventing Mycobacterium avium complex in patients who are using protease inhibitors: a cost-effectiveness analysis. |
1998 |
AIDS |
pmid:9727572
|
Bermudez LE et al. |
Clarithromycin significantly improves interleukin-12-mediated anti-Mycobacterium avium activity and abolishes toxicity in mice. |
1998 |
J. Infect. Dis. |
pmid:9728568
|
Gorski JC et al. |
The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin. |
1998 |
Clin. Pharmacol. Ther. |
pmid:9728893
|
Barzilai A et al. |
Successful treatment of disseminated Mycobacterium simiae infection in AIDS patients. |
1998 |
Scand. J. Infect. Dis. |
pmid:9730300
|
Graham DY et al. |
Effect of H. pylori infection and CagA status on leukocyte counts and liver function tests: extra-gastric manifestations of H. pylori infection. |
1998 |
Helicobacter |
pmid:9731987
|
Bazzoli F et al. |
Efficacy of lansoprazole in eradicating Helicobacter pylori: a meta-analysis. |
1998 |
Helicobacter |
pmid:9731991
|
Lanza FL et al. |
Ranitidine bismuth citrate plus clarithromycin: a dual therapy regimen for patients with duodenal ulcer. |
1998 |
Helicobacter |
pmid:9731994
|
Vakil N et al. |
Clarithromycin-resistant Helicobacter pylori in patients with duodenal ulcer in the United States. |
1998 |
Am. J. Gastroenterol. |
pmid:9732920
|
Chu KM et al. |
A prospective randomized trial comparing the use of omeprazole-based dual and triple therapy for eradication of Helicobacter pylori. |
1998 |
Am. J. Gastroenterol. |
pmid:9732921
|
Lamouliatte H et al. |
Dual therapy using a double dose of lansoprazole with amoxicillin versus triple therapy using a double dose of lansoprazole, amoxicillin, and clarithromycin to eradicate Helicobacter pylori infection: results of a prospective randomized open study. |
1998 |
Am. J. Gastroenterol. |
pmid:9732938
|
Alder JD et al. |
Dynamics of clarithromycin and azithromycin efficacies against experimental Haemophilus influenzae pulmonary infection. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9736568
|
Siu LK et al. |
Evaluation of a selective transport medium for gastric biopsy specimens to be cultured for Helicobacter pylori. |
1998 |
J. Clin. Microbiol. |
pmid:9738066
|
Sevin E et al. |
Co-detection of Helicobacter pylori and of its resistance to clarithromycin by PCR. |
1998 |
FEMS Microbiol. Lett. |
pmid:9742711
|
Hiratsuka T et al. |
[Severe bronchorrhea accompanying alveolar cell carcinoma: treatment with clarithromycin and inhaled beclomethasone]. |
1998 |
Nihon Kokyuki Gakkai Zasshi |
pmid:9742869
|
Huang WH et al. |
New one-week, low-dose triple therapy for the treatment of duodenal ulcer with Helicobacter pylori infection. |
1998 |
Zhonghua Yi Xue Za Zhi (Taipei) |
pmid:9745160
|
Apseloff G et al. |
Comparison of azithromycin and clarithromycin in their interactions with rifabutin in healthy volunteers. |
1998 |
J Clin Pharmacol |
pmid:9753212
|
Gikas A et al. |
In vitro susceptibility of Coxiella burnetii to trovafloxacin in comparison with susceptibilities to pefloxacin, ciprofloxacin, ofloxacin, doxycycline, and clarithromycin. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9756789
|
Debets-Ossenkopp YJ et al. |
Explaining the bias in the 23S rRNA gene mutations associated with clarithromycin resistance in clinical isolates of Helicobacter pylori. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9756790
|
Greenblatt DJ et al. |
Inhibition of triazolam clearance by macrolide antimicrobial agents: in vitro correlates and dynamic consequences. |
1998 |
Clin. Pharmacol. Ther. |
pmid:9757151
|
Denys A |
[Theoretical basis for the antibiotic therapy of the upper part of the respiratory system]. |
1997 |
Otolaryngol Pol |
pmid:9757681
|
Kubas G and Gospodarek T |
[The use of clarithromycin and amoxycillin in pediatric acute otitis media]. |
1997 |
Otolaryngol Pol |
pmid:9757683
|
Pontani D et al. |
Susceptibility of European respiratory tract isolates to trovafloxacin, ciprofloxacin, clarithromycin, azithromycin and ampicillin. |
1998 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:9758284
|
Hawkey CJ et al. |
Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention. |
1998 |
Lancet |
pmid:9759744
|
Mégraud F and Doermann HP |
Clinical relevance of resistant strains of Helicobacter pylori: a review of current data. |
1998 |
Gut |
pmid:9764043
|
Heald AE et al. |
Taste and smell complaints in HIV-infected patients. |
1998 |
AIDS |
pmid:9764787
|
Horgen L et al. |
Postantibiotic effect of amikacin, rifampin, sparfloxacin, clofazimine and clarithromycin against Mycobacterium avium. |
1997 |
Res. Microbiol. |
pmid:9765852
|
Pipkin GA et al. |
Review article: one-week clarithromycin triple therapy regimens for eradication of Helicobacter pylori. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9768524
|
Louw JA et al. |
Helicobacter pylori eradication and ulcer healing with daily lansoprazole, plus 1 or 2 weeks co-therapy with amoxycillin and clarithromycin. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9768531
|
Laine L et al. |
Low rate of emergence of clarithromycin-resistant Helicobacter pylori with amoxycillin co-therapy. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9768532
|
Mukunda BN et al. |
Clarithromycin therapy for bacillary peliosis did not prevent bacillary angiomatosis. |
1998 |
Clin. Infect. Dis. |
pmid:9770180
|
Stack WA et al. |
Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration. |
1998 |
Am. J. Gastroenterol. |
pmid:9772054
|
Adamek RJ and Bethke TD |
Cure of Helicobacter pylori infection and healing of duodenal ulcer: comparison of pantoprazole-based one-week modified triple therapy versus two-week dual therapy. The International Pantoprazole HP Study Group. |
1998 |
Am. J. Gastroenterol. |
pmid:9772056
|
Stolte M et al. |
Cure of autoimmune gastritis by Helicobacter pylori eradication in a 21-year-old male. |
1998 |
Z Gastroenterol |
pmid:9773482
|
Pina M et al. |
Detection of point mutations associated with resistance of Helicobacter pylori to clarithromycin by hybridization in liquid phase. |
1998 |
J. Clin. Microbiol. |
pmid:9774580
|
Griffith DE |
Mycobacteria as pathogens of respiratory infection. |
1998 |
Infect. Dis. Clin. North Am. |
pmid:9779380
|
Casswall TH et al. |
One-week treatment with omeprazole, clarithromycin, and metronidazole in children with Helicobacter pylori infection. |
1998 |
J. Pediatr. Gastroenterol. Nutr. |
pmid:9779970
|
Aberg JA et al. |
Eradication of AIDS-related disseminated mycobacterium avium complex infection after 12 months of antimycobacterial therapy combined with highly active antiretroviral therapy. |
1998 |
J. Infect. Dis. |
pmid:9780266
|
González Carro P et al. |
[Efficacy of an ultrashort protocol in the eradication of Helicobacter pylori]. |
1998 |
Rev Esp Enferm Dig |
pmid:9780793
|
Gangadharam PR |
Clarithromycin for non-mycobacterial diseases? |
1998 |
Int. J. Tuberc. Lung Dis. |
pmid:9783536
|
Hua J et al. |
Characterization of clinical isolates of Helicobacter pylori in Singapore. |
1998 |
Microbios |
pmid:9785486
|
Sádaba B et al. |
Concurrent clarithromycin and cyclosporin A treatment. |
1998 |
J. Antimicrob. Chemother. |
pmid:9786481
|
Finkenbine RD and Frye MD |
Case of psychosis due to prednisone-clarithromycin interaction. |
1998 |
Gen Hosp Psychiatry |
pmid:9788033
|
Borody TJ |
Helicobacter pylori eradication failure--'salvage' therapies needed. |
1998 |
Ital J Gastroenterol Hepatol |
pmid:9789131
|
Coudron PE and Stratton CW |
The bactericidal activity of clarithromycin versus ampicillin alone and in combination with omeprazole and/or bismuth against clarithromycin-susceptible and clarithromycin-resistant strains of Helicobacter pylori. |
1998 |
Diagn. Microbiol. Infect. Dis. |
pmid:9791756
|
Niang M et al. |
[Painful nodular lesions]. |
1998 |
Rev Med Interne |
pmid:9793156
|
Saika T et al. |
[A mechanism of clarithromycin resistance in Helicobacter pylori]. |
1998 |
Kansenshogaku Zasshi |
pmid:9796191
|
Langan C et al. |
Short-course cefuroxime axetil therapy in the treatment of acute exacerbations of chronic bronchitis. |
1998 Jul-Aug |
Int. J. Clin. Pract. |
pmid:9796558
|
Piccolomini R et al. |
Bacteriostatic and bactericidal in vitro activities of clarithromycin and erythromycin against periodontopathic Actinobacillus actinomycetemcomitans. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9797240
|
Horgen L et al. |
Pulsed-exposure and postantibiotic leukocyte enhancement effects of amikacin, clarithromycin, clofazimine, and rifampin against intracellular Mycobacterium avium. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9797242
|
Ouellet D et al. |
Pharmacokinetic interaction between ritonavir and clarithromycin. |
1998 |
Clin. Pharmacol. Ther. |
pmid:9797791
|
Chodosh S et al. |
Efficacy of oral ciprofloxacin vs. clarithromycin for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group. |
1998 |
Clin. Infect. Dis. |
pmid:9798025
|
Craft JC et al. |
Clarithromycin resistance and susceptibility patterns of Mycobacterium avium strains isolated during prophylaxis for disseminated infection in patients with AIDS. |
1998 |
Clin. Infect. Dis. |
pmid:9798037
|
Shafran SD |
Clarithromycin prophylaxis for disseminated Mycobacterium avium complex infection--efficacy and acquired resistance. |
1998 |
Clin. Infect. Dis. |
pmid:9798038
|
Cestari R |
Ranitidine bismuth citrate (RBC) based triple therapy for 7 days is more effective than RBC plus clarithromycin for 14 days in dyspeptic patients with Helicobacter pylori infection. H. Pylori Lombardy Group. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9798804
|
Spadaccini A et al. |
Triple regimens using lansoprazole or ranitidine bismuth citrate for Helicobacter pylori eradication. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9798805
|
Bortolotti M et al. |
Effects of oral clarithromycin and amoxycillin on interdigestive gastrointestinal motility of patients with functional dyspepsia and Helicobacter pylori gastritis. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9798808
|
Hynes B |
Contact granulomas. |
1998 |
J Otolaryngol |
pmid:9800633
|
Fabry W et al. |
Comparison of the E test and a proportion dilution method for susceptibility testing of Mycobacterium tuberculosis. |
1995 |
Zentralbl. Bakteriol. |
pmid:9810662
|
Abouesh A and Hobbs WR |
Clarithromycin-induced mania. |
1998 |
Am J Psychiatry |
pmid:9812131
|
Miehlke S et al. |
Comparison of omeprazole, metronidazole and clarithromycin with omeprazole/amoxicillin dual-therapy for the cure of Helicobacter pylori infection. |
1998 Nov-Dec |
Digestion |
pmid:9813387
|
Clark CL et al. |
Antipneumococcal activities of levofloxacin and clarithromycin as determined by agar dilution, microdilution, E-test, and disk diffusion methodologies. |
1998 |
J. Clin. Microbiol. |
pmid:9817876
|
Björkholm B et al. |
Rapid PCR detection of Helicobacter pylori-associated virulence and resistance genes directly from gastric biopsy material. |
1998 |
J. Clin. Microbiol. |
pmid:9817898
|
Arimori K et al. |
Characteristic difference in gastrointestinal excretion of clarithromycin and roxithromycin. |
1998 |
Biopharm Drug Dispos |
pmid:9818709
|
Cirioni O et al. |
In-vitro activity of lytic peptides alone and in combination with macrolides and inhibitors of dihydrofolate reductase against Pneumocystis carinii. |
1998 |
J. Antimicrob. Chemother. |
pmid:9818742
|
Vrioni G et al. |
Treatment of disseminated Mycobacterium genavense infection in a murine model with ciprofloxacin, amikacin, ethambutol, clarithromycin and rifabutin. |
1998 |
J. Antimicrob. Chemother. |
pmid:9818747
|
Champney WS and Burdine R |
Macrolide antibiotic inhibition of translation and 50S ribosomal subunit assembly in methicillin-resistant Staphylococcus aureus cells. |
1998 |
Microb. Drug Resist. |
pmid:9818968
|
Mermelstein HT |
Clarithromycin-induced delirium in a general hospital. |
1998 Nov-Dec |
Psychosomatics |
pmid:9819955
|
Murata H et al. |
Evaluation of the PyloriTek test for detection of Helicobacter pylori infection in cases with and without eradication therapy. |
1998 |
Am. J. Gastroenterol. |
pmid:9820380
|
Laine L et al. |
Twice-daily, 10-day triple therapy with omeprazole, amoxicillin, and clarithromycin for Helicobacter pylori eradication in duodenal ulcer disease: results of three multicenter, double-blind, United States trials. |
1998 |
Am. J. Gastroenterol. |
pmid:9820381
|
Kaeser YA et al. |
Severe hypotension and bradycardia associated with verapamil and clarithromycin. |
1998 |
Am J Health Syst Pharm |
pmid:9825040
|
Ward TT et al. |
Randomized, open-label trial of azithromycin plus ethambutol vs. clarithromycin plus ethambutol as therapy for Mycobacterium avium complex bacteremia in patients with human immunodeficiency virus infection. Veterans Affairs HIV Research Consortium. |
1998 |
Clin. Infect. Dis. |
pmid:9827282
|
Howden CW and Hunt RH |
Treating Helicobacter pylori. |
1998 |
Arch. Intern. Med. |
pmid:9827792
|
Anzueto A et al. |
Etiology, susceptibility, and treatment of acute bacterial exacerbations of complicated chronic bronchitis in the primary care setting: ciprofloxacin 750 mg b.i.d. versus clarithromycin 500 mg b.i.d. Bronchitis Study Group. |
1998 Sep-Oct |
Clin Ther |
pmid:9829441
|
Dhawan VK et al. |
Vancomycin-resistant enterococcal colonization in nonhospitalized HIV-infected patients. |
1998 |
West. J. Med. |
pmid:9830355
|
Shafran SD |
Prevention and treatment of disseminated Mycobacterium avium complex infection in human immunodeficiency virus-infected individuals. |
1998 Jul-Sep |
Int. J. Infect. Dis. |
pmid:9831675
|
Valsecchi R and Pigatto P |
Chronic urticaria and Helicobacter pylori. |
1998 |
Acta Derm. Venereol. |
pmid:9833044
|
Sackoff J et al. |
Prophylaxis for opportunistic infections among HIV-infected patients receiving medical care. |
1998 |
J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. |
pmid:9833748
|
van Haarst AD et al. |
The influence of cisapride and clarithromycin on QT intervals in healthy volunteers. |
1998 |
Clin. Pharmacol. Ther. |
pmid:9834046
|
Xia HH et al. |
Metronidazole- and clarithromycin-resistant Helicobacter pylori in dyspeptic patients in western Sydney as determined by testing multiple isolates from different gastric sites. |
1998 |
J. Gastroenterol. Hepatol. |
pmid:9835322
|
Berry V et al. |
Bacteriological efficacies of three macrolides compared with those of amoxicillin-clavulanate against Streptococcus pneumoniae and Haemophilus influenzae. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9835514
|
Hogan PA and Sheehan DJ |
Macrolide susceptibility and beta-lactamase production among haemophilus influenzae isolates in the United States, 1996-1997. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9835536
|
Borody TJ et al. |
Eradication therapies for Helicobacter pylori. |
1998 |
J. Gastroenterol. |
pmid:9840019
|
Moayyedi P et al. |
Relevance of antibiotic sensitivities in predicting failure of omeprazole, clarithromycin, and tinidazole to eradicate Helicobacter pylori. |
1998 |
J. Gastroenterol. |
pmid:9840021
|
Ohkusa T et al. |
Disappearance of hyperplastic polyps in the stomach after eradication of Helicobacter pylori. A randomized, clinical trial. |
1998 |
Ann. Intern. Med. |
pmid:9841603
|
Kato S et al. |
Safety and efficacy of one-week triple therapy for eradicating Helicobacter pylori in children. |
1998 |
Helicobacter |
pmid:9844069
|
Gisbert JP et al. |
[Omeprazole plus 2 antibiotics for the eradication of H. pylori, are 5 days of treatment sufficient?]. |
1998 |
Rev Clin Esp |
pmid:9844453
|
Gisbert JP et al. |
[Role of pantoprazole in the eradicating treatment of Helicobacter pylori]. |
1998 |
Rev Clin Esp |
pmid:9844458
|
Gudjonsson H et al. |
High Helicobacter pylori eradication rate with a 1-week regimen containing ranitidine bismuth citrate. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9845401
|
Coudron PE and Stratton CW |
In-vitro evaluation of nitrofurantoin as an alternative agent for metronidazole in combination antimicrobial therapy against Helicobacter pylori. |
1998 |
J. Antimicrob. Chemother. |
pmid:9848452
|
Cadwgan AM et al. |
Neisseria meningitidis W135 pneumonia with sepicaemia in a nonogenarian. |
1998 |
Scott Med J |
pmid:9854302
|
Shimoyama T et al. |
Healing of cimetidine-resistant Ménétrier's disease by eradication of Helicobacter pylori infection. |
1998 |
J. Clin. Gastroenterol. |
pmid:9855268
|
Adelglass J et al. |
A multicenter, investigator-blinded, randomized comparison of oral levofloxacin and oral clarithromycin in the treatment of acute bacterial sinusitis. |
1998 Nov-Dec |
Pharmacotherapy |
pmid:9855324
|
Blum AL et al. |
Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group. |
1998 |
N. Engl. J. Med. |
pmid:9862942
|
Maeda S et al. |
Helicobacter pylori specific nested PCR assay for the detection of 23S rRNA mutation associated with clarithromycin resistance. |
1998 |
Gut |
pmid:9863474
|
Al-Sibai MB et al. |
Ocular penetration of oral clarithromycin in humans. |
1998 |
J Ocul Pharmacol Ther |
pmid:9867340
|
Wallace RJ and Brown BA |
Catheter sepsis due to Mycobacterium chelonae. |
1998 |
J. Clin. Microbiol. |
pmid:9867491
|
Shafran SD et al. |
Does in vitro susceptibility to rifabutin and ethambutol predict the response to treatment of Mycobacterium avium complex bacteremia with rifabutin, ethambutol, and clarithromycin? Canadian HIV Trials Network Protocol 010 Study Group. |
1998 |
Clin. Infect. Dis. |
pmid:9868650
|